Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma

M. Hiasa, J. Teramachi, A. Oda, R. Amachi, T. Harada, S. Nakamura, H. Miki, S. Fujii, K. Kagawa, K. Watanabe, I. Endo, Y. Kuroda, T. Yoneda, D. Tsuji, M. Nakao, E. Tanaka, K. Hamada, S. Sano, K. Itoh, T. MatsumotoM. Abe

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences